Numetah G13% E Prematures (Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio)

Numetah G13% E Prematures contains an amino‑acid blend that acts on protein metabolism pathways.

• Metabolic support in malnutrition: helps restore nitrogen balance and supports tissue repair.
• Pre‑ and post‑operative care: contributes to wound healing and recovery of lean body mass.
• Chronic disease management: assists patients with catabolic conditions such as COPD or heart failure to maintain muscle mass.
• Critical care nutrition: provides essential amino acids for patients on ventilator support or receiving parenteral nutrition.
• Pediatric nutrition: supports growth and development in children with increased protein requirements.

• The formulation supplies essential and conditionally essential amino acids that are directly incorporated into protein synthesis pathways. By increasing the availability of substrates for ribosomal translation, it enhances muscle protein accretion, supports gluconeogenesis, and contributes to nitrogen balance. The amino acids also act as precursors for neurotransmitters and metabolic intermediates, influencing cellular energy metabolism and immune function.

Side effects are generally mild and related to the oral delivery of an amino‑acid mixture.

Common Side Effects

• Nausea: occasional mild nausea after ingestion.
• Abdominal discomfort: mild cramping or bloating.
• Diarrhea: loose stools in a minority of users.
• Metallic taste: transient metallic sensation in the mouth.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, or swelling of the face, lips, or tongue.
• Hyperammonemia: elevated blood ammonia levels in patients with severe liver dysfunction.
• Metabolic imbalance: rare disturbances in amino‑acid plasma concentrations.
• Renal impairment exacerbation: worsening kidney function in patients with pre‑existing renal disease.

Before using Numetah G13% E Prematures, consider the following safety measures:

• Assess renal function: evaluate kidney performance before initiating therapy.
• Monitor liver status: check hepatic function in patients with known liver disease.
• Observe for hypersensitivity: discontinue if signs of allergic reaction appear.
• Adjust in metabolic disorders: use caution in inherited amino‑acid metabolism disorders.
• Review concomitant nutrition: ensure total protein intake does not exceed recommended levels.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Numetah G13% E Prematures may interact with certain medications and nutrients.

Major Interactions (Avoid)

• Levodopa therapy: high‑protein meals can reduce levodopa absorption.
• Anticonvulsants: some may alter amino‑acid plasma levels.

Moderate Interactions (Monitor Closely)

• Diuretics: increased nitrogen load may affect fluid balance.
• Warfarin: protein intake can influence INR stability.
• Iron supplements: concurrent intake may reduce amino‑acid absorption.
• Thyroid hormone replacement: high protein may affect hormone metabolism.